The NHS has launched a new, one-off vaccination programme offering protection against Meningococcal Group B (MenB) to one million young people across the UK. The rollout comes following a series of unusual disease clusters, including the largest MenB outbreak recorded in Kent this spring, and aims to vaccinate students heading to university or residential further education this autumn, according to NHS guidance.
Why the MenB Vaccine Rollout Targets Young Adults
While the MenB vaccine has been available to infants for years, it was previously not routinely offered to older teenagers. According to data provided by the NHS, MenB bacteria accounts for 82.6% of all meningitis cases in the UK. Historically, the vaccine was prioritized for babies due to their higher vulnerability, leaving a gap in protection for the 15-to-25 age group.
This demographic is now considered the second most at-risk group, particularly those living in close-proximity settings like university halls. The bacteria spreads through intimate contact, such as sharing drinks, vaping, or kissing. Dr. Tom Nutt, chief executive of the Stroud-based charity Meningitis Now, notes that the disease is lethal for one in ten people and can progress to death within 24 hours.
Did you know?
Meningitis B is the most common cause of bacterial meningitis in the UK. Experts at the UK government level recently recommended that all teenagers be offered a routine free vaccination at age 15 to combat the spread.
Eligibility and How to Access the Vaccine
The new programme is designed for specific student cohorts to ensure they are protected before the start of the autumn term. Eligibility includes:
- Pupils in Year 13 (England and Wales), Year 14 (Northern Ireland), and S6 (Scotland).
- Students aged 18 to 25 entering university or residential further education for the first time.
- Individuals born on or after 21 July 2001 who are starting as residential students at a further education college.
Eligible individuals can book appointments through the NHS National Booking Service or participating local pharmacies. Those aged 17 and 18 who are registered with a GP are encouraged to use the national booking portal to secure their two-dose course.
The Human Impact: A Call for Awareness
The drive for increased vaccination access is supported by families affected by the disease. Michelle Bresnahan, whose 16-year-old son Ryan died from MenB in 2010, has campaigned for years to expand access to the jab. She described her son as a “talented” and “kind” sportsman who died “incredibly quickly” at a time when no vaccine was available for his age group.
“Vaccination saves lives and we never had that opportunity,” Bresnahan said. She urges all eligible young people to book their doses before heading to university in September, describing the disease as “horrible.”
Pro Tip:
If you are heading to university this year, don’t wait until you arrive on campus. Book your first dose now at a local pharmacy to ensure you have the necessary time to complete the two-dose course before the autumn semester begins.
FAQ: Understanding Meningitis B Risks
What are the primary symptoms of meningitis?
Common symptoms include a severe headache, a high temperature, and the appearance of a rash. If these symptoms occur, medical attention should be sought immediately due to the rapid progression of the infection.
Is the vaccine free for all students?
The current programme is a one-off, free offering for specific age groups and students entering residential education. Previously, those outside the infant age bracket had to pay approximately £220 privately for the vaccine.
How does the bacteria spread?
The MenB bacteria is transmitted through close contact. This includes sharing vapes, drinks, or living in crowded residential environments like student accommodation.
Have you or a family member been affected by meningitis, or do you have questions about the new rollout? Share your thoughts in the comments below or subscribe to our health newsletter for the latest NHS updates.
Worth a look